Protina Takes Over Exclusive Distribution for URGO Products in Germany
The pharmaceutical company Protina, based in Ismaning near Munich, has announced a major new partnership. Effective immediately, the company is taking over the exclusive distribution for URGO Healthcare in the German market. This collaboration represents a significant step for both companies and will change the range of products available in German pharmacies.
At the heart of the cooperation are URGO's so-called Filmogel solutions. This is an innovative and patented technology for wound care. These liquid plasters form a protective film on the skin and help with various issues such as small wounds, cold sores, or cracked skin.
For Protina, this contract represents a major expansion of its own portfolio. In Germany, the company has primarily been known for its mineral supplements until now. Through URGO Healthcare's products, the company can now also offer modern solutions in the field of medical skin care and wound healing.
URGO Healthcare is an internationally active company from France, known for its research in the medical field. In Protina, the company has now found a strong partner with extensive experience in the German pharmacy market. The goal is to increase awareness of these specialized health products throughout Germany.
For customers in Germany, this news means that the availability of these specialized medical products in local pharmacies will be improved. In the future, pharmacy professionals will be better equipped to provide information about the benefits of Filmogel technology.
In summary, this cooperation demonstrates the importance of strategic partnerships in the healthcare sector. By combining French innovation with German distribution expertise, patients in Germany are expected to gain better access to modern treatment methods for everyday health problems.